Andrew Schwab shares perspectives on federal healthcare policy, advocacy strategy, and industry developments through media appearances, interviews, and analysis.
“There is real bipartisan unease around consolidation and lack of transparency in the system,” he said. “All those things could get thrown into the conversation in a way that many on Wall Street may not be expecting.”
While investors are probably right to assume some easing up of regulatory scrutiny under Trump, they shouldn’t expect a total letup. There is at least some support on both sides of the aisle to tackle the myriad problems with America’s healthcare system, says Andrew Schwab, founder of Washington-based Platform Government Strategies.
“There is real bipartisan unease around consolidation and lack of transparency in the system,” he said. “All those things could get thrown into the conversation in a way that many on Wall Street may not be expecting.”
With the election over and President Donald Trump officially inaugurated, all eyes in healthcare are turning toward how the sector might change. But as the first two weeks of his second term showed, keeping up with Trump’s actions—and their ramifications—requires full-time focus.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Amet aliquam id diam maecenas ultricies mi eget mauris.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Amet aliquam id diam maecenas ultricies mi eget mauris.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Amet aliquam id diam maecenas ultricies mi eget mauris.
